• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ADMEDUS REGEN PTY LTD CARDIOCEL NEO; INTRACARDIAC PATCH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ADMEDUS REGEN PTY LTD CARDIOCEL NEO; INTRACARDIAC PATCH Back to Search Results
Catalog Number UC0404N
Device Problem Insufficient Information (3190)
Patient Problem Stenosis (2263)
Event Date 04/13/2020
Event Type  Injury  
Manufacturer Narrative
Review of batch record did not identify any deviations or errors.Investigation and interviews with clinicians have been scheduled.Adverse events associated with bioprosthetic pericardial patches that have been reported in the literature, have included flow obstruction.
 
Event Description
Re-operation for occluded lpa from prior tof repair with left pulmonary arterioplasty.Cardiocel used to augment lpa.Re-stenosed the lpa within 2 months (severe, near occlusion) and required balloon and stent in cath lab on (b)(6) 2022 with multiple procedures to up-size the stent for somatic growth ((b)(6) 2022, (b)(6) 2021.).
 
Event Description
Re-operation for occluded lpa from prior to f repair with left pulmonary arterioplasty.Cardiocel used to augment lpa.Restenosed the lpa within 2 months (severe, near occlusion) and required balloon and stent in cath lab on (b)(6) 2020 with multiple procedures to up-size the stent for somatic growth ((b)(6) 2020, (b)(6) 2021).
 
Manufacturer Narrative
Review of batch record did not identify any deviations or errors.Investigation has been completed and interviews with clinicians have been performed.The events occurred in 7 patients out of 140 treated with cardiocel.A call with physicians occurred to discuss the procedure and their findings.It was noted the events happened in cases of pa repair.Batch record review determined that all products met acceptance criteria.There were no manufacturing changes during this time period to suggest a change on the product.While anteris continues to monitor, it appears at this time the event to be unlikely related to the product but rather associated with the complex intervention and challenges of vascular reconstruction in these young patients.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARDIOCEL NEO
Type of Device
INTRACARDIAC PATCH
Manufacturer (Section D)
ADMEDUS REGEN PTY LTD
26 harris road
malaga, western australia 6080
AS  6080
Manufacturer (Section G)
ADMEDUS REGEN PTY LTD
26 harris road
malaga, western australia 6080
AS   6080
Manufacturer Contact
jim chapman
860 blue gentien road
suite 340
eagan, MN 55121
6514930606
MDR Report Key15739279
MDR Text Key303140183
Report Number3012664855-2022-00005
Device Sequence Number1
Product Code DXZ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K130872
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type User Facility,Distributor
Reporter Occupation Risk Manager
Type of Report Initial,Followup
Report Date 02/08/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/04/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/11/2022
Device Catalogue NumberUC0404N
Device Lot NumberM19042-03
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received10/05/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/11/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening;
Patient Age3 YR
Patient SexFemale
Patient Weight12 KG
-
-